Antibacterial Therapy with Sterically Stabilized Liposome Formulations

  • Irma A. J. M. Bakker-Woudenberg
  • Gerrit Storm
  • Martin C. Woodle
Part of the Biotechnology Intelligence Unit book series (BIOIU)


In the last few years a major breakthrough with respect to liposomal delivery of antibiotics has occurred in the development of liposome formulations with long circulation half-lives.1–4


Visceral Leishmaniasis Antimicrob Agent Mononuclear Phagocyte System Conventional Amphotericin Mycobacterium Avium Complex Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Woodle MC. Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. Chem Phys Lipids 1993; 64: 249–262.PubMedCrossRefGoogle Scholar
  2. 2.
    Woodle MC, Newman MS, Cohen JA. Sterically stabilized liposomes: physical and biological properties. J Drug Targeting 1994; 2397–403.Google Scholar
  3. 3.
    Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994; 15: 215–220.PubMedCrossRefGoogle Scholar
  4. 4.
    Marjan JMJ, Allen TM. Long-circulating liposomes: past, present and future. Biotechnol Adv 1996; 14: 51–175.CrossRefGoogle Scholar
  5. 5.
    Bakker-Woudenberg IAJM. Liposomes in the treatment of parasitic, viral, fungal and bacterial infections. J Liposome Res 1995; 5: 169–191.Google Scholar
  6. 6.
    Bakker-Woudenberg IAJM. Delivery of antimicrobials to infected tissue macrophages. Adv Drug Deliv Rev 1995; 17:5-20.Google Scholar
  7. 7.
    Leenders ACAP, de Marie S. The use of lipid formulations of amphotericin B for systemic fungal infections. Leukemia 1996; 10: 1570–1575.Google Scholar
  8. 8.
    Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996; 22 (Suppl. 2): S133–144.PubMedCrossRefGoogle Scholar
  9. 9.
    Vladimirsky MA, Ladigina GA. Antibacterial activity of liposome-encapsulated streptomycin in mice infected with Mycobacterium tuberculosis. Biomedicine 1982; 36: 375–377.Google Scholar
  10. 10.
    Ladigina GA, Vladimirsky MA. The comparative pharmacokinetics of 3Hdihydrostreptomycin in solution and liposomal form in normal and Mycobacterium tuberculosis infected mice. Biomed Pharmacother 1986; 40: 416–420.PubMedGoogle Scholar
  11. 11.
    Düzgünes N, Perumal VK, Kesavalu L, Goldstein JA, Debs RJ, Gangadharam PRJ. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother 1988; 32: 1404–1411.PubMedCrossRefGoogle Scholar
  12. 12.
    Cynamon MH, Swenson CE, Palmer GS, Ginsberg RS. Liposome-encapsulatedamikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother 1989; 33: 1179–1183.PubMedCrossRefGoogle Scholar
  13. 13.
    Klemens SP, Cynamon MH, Swenson CE, Ginsberg RS. Liposome-encapsulated gentamicin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother 1990; 34: 967–970.PubMedCrossRefGoogle Scholar
  14. 14.
    Düzgünes N, Ashtekar DR, Flasher DL et al. Treatment of Mycobacterium aviumintracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. J Infect Dis 1991; 164: 143–151.PubMedCrossRefGoogle Scholar
  15. 15.
    Saito H, Tomioka H. Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice. Antimicrob Agents Chemother 1989; 33: 429–433.PubMedCrossRefGoogle Scholar
  16. 16.
    Tomioka H, Saito H, Sato K, Yoneyama T. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. Am Rev Respir Dis 1991; 144: 575–579.PubMedCrossRefGoogle Scholar
  17. 17.
    Le Conte P, Le Gallou F, Potel G, Struillou L, Baron D, Drugeon HB. Pharmacokinetics, toxicity and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob Agents Chemother 1994; 38: 2695–2701.Google Scholar
  18. 18.
    Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Amer J Pathol 1988; 133: 95–109.Google Scholar
  19. 19.
    Jain RK. Vascular and intestitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990; 9: 253–266.PubMedCrossRefGoogle Scholar
  20. 20.
    Wu NZ, Dewhirst MW. Measurement of material extravasation in microvascular networks using fluorescence video-microscopy. Microvascular Res 1993; 46: 231–253.CrossRefGoogle Scholar
  21. 21.
    Huang SK, Lee KD, Hong K et al. Microscopic localization of sterically-stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 1992; 52: 5135–5143.PubMedGoogle Scholar
  22. 22.
    Wu NZ, Da D, Rudoll TL et al. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 1993; 53: 3765–3770.PubMedGoogle Scholar
  23. 23.
    Yuan F, Leunig M, Huang SK et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 1994; 54: 3352–3356.PubMedGoogle Scholar
  24. 24.
    Lasic DD, Martin FJ (eds). Stealth Liposomes. Boca Raton, FL: CRC Press, 1995.Google Scholar
  25. 25.
    Huang SK, Hong K, Lee KD, Papahadjopoulos D, Friend DS. Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues. Biochim Biophys Acta 1991; 1069: 117–121.PubMedCrossRefGoogle Scholar
  26. 26.
    Bakker-Woudenberg IAJM, Lokerse AF, ten Kate MT, Mouton JW, Woodle MC, Storm G. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae infected lung tissue. J Infect Dis 1993; 168: 164–171.Google Scholar
  27. 27.
    Bakker-Woudenberg IAJM, ten Kate MT, Stearne-Cullen LET, Woodle MC. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae infected lung tissue. J Infect Dis 1995; 171: 938–947.Google Scholar
  28. 28.
    Gangadharam PRJ, Ashtekar DR, Flasher DL, Düzgünes N. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob Agents Chemother 1995; 39: 725–730.PubMedCrossRefGoogle Scholar
  29. 29.
    Harvie P, Désormeaux A, Bergeron MC, Tremblay M, Beauchamp D, Poulin L, Bergeron MG. Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2’, 3’-dideoxyinosine. Antimicrob Agents Chemother 1996; 40: 225–229.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Irma A. J. M. Bakker-Woudenberg
  • Gerrit Storm
  • Martin C. Woodle

There are no affiliations available

Personalised recommendations